Researchers at the University of Tennessee are using AI and a new tool to determine how much breast cancer is in a patient's body.

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

The FDA clears GL-IL2-138, a groundbreaking oral drug modulating natural IL-2, set to revolutionize treatment in oncology.

In their appeal, the NAACP and other groups argued that the SCHD put xAI profits over Black people's health, granting ...

Alphabet spinoff SandboxAQ is teaming up with iOncologi to build a new mRNA vaccine for a common and aggressive brain tumor ...

Researchers compared radiologist performance and visual search patterns when reading screening mammograms with and without an AI decision support system.

Soon, many patients might initiate contact with the health system not by speaking with a call center worker or receptionist, ...

University of Tennessee researchers are using artificial intelligence to more quickly determine treatment plans for breast cancer patients.

As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances in diagnosis and treatment.

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed ...

The system will then be able to compare it with cancer staging data to determine what stage of breast cancer a patient has.

University of Tennessee researchers are turning to artificial intelligence to come up with treatment plans for breast cancer patients more quickly.